C130H114ClF12N35O17 — CID 157336998
tert-butyl 4-[2-[[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]oxy]ethyl]piperidine-1-carboxylate;N-[5-[6-chloro-4-(hydroxymethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,6-difluorobenzamide;2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-6-ethoxy-3H-benzimidazole-5-carboxylic acid;2,6-difluoro-N-[5-[6-(2-piperidin-4-ylethoxy)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-(7H-purin-8-yl)-1H-pyrazol-4-yl]benzamide;N-[5-[5-ethoxy-6-(morpholine-4-carbonyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,6-difluorobenzamide (PubChem CID 157336998) has the molecular formula C130H114ClF12N35O17 and a molecular weight of 2702.00 g/mol. Its IUPAC name is tert-butyl 4-[2-[[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]oxy]ethyl]piperidine-1-carboxylate;N-[5-[6-chloro-4-(hydroxymethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,6-difluorobenzamide;2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-6-ethoxy-3H-benzimidazole-5-carboxylic acid;2,6-difluoro-N-[5-[6-(2-piperidin-4-ylethoxy)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-(7H-purin-8-yl)-1H-pyrazol-4-yl]benzamide;N-[5-[5-ethoxy-6-(morpholine-4-carbonyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,6-difluorobenzamide.
| Compound Name | tert-butyl 4-[2-[[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]oxy]ethyl]piperidine-1-carboxylate;N-[5-[6-chloro-4-(hydroxymethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,6-difluorobenzamide;2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-6-ethoxy-3H-benzimidazole-5-carboxylic acid;2,6-difluoro-N-[5-[6-(2-piperidin-4-ylethoxy)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-(7H-purin-8-yl)-1H-pyrazol-4-yl]benzamide;N-[5-[5-ethoxy-6-(morpholine-4-carbonyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,6-difluorobenzamide |
|---|---|
| PubChem CID | 157336998 |
| Molecular Formula | C130H114ClF12N35O17 |
| Molecular Weight | 2702.00 g/mol |
| Exact Mass | 2699.86 |
| IUPAC Name | tert-butyl 4-[2-[[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-3H-benzimidazol-5-yl]oxy]ethyl]piperidine-1-carboxylate;N-[5-[6-chloro-4-(hydroxymethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,6-difluorobenzamide;2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-6-ethoxy-3H-benzimidazole-5-carboxylic acid;2,6-difluoro-N-[5-[6-(2-piperidin-4-ylethoxy)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-(7H-purin-8-yl)-1H-pyrazol-4-yl]benzamide;N-[5-[5-ethoxy-6-(morpholine-4-carbonyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,6-difluorobenzamide |
| SMILES | CC(C)(C)OC(=O)N1CCC(CCOc2ccc3nc(-c4[nH]ncc4NC(=O)c4c(F)cccc4F)[nH]c3c2)CC1.CCOc1cc2nc(-c3[nH]ncc3NC(=O)c3c(F)cccc3F)[nH]c2cc1C(=O)N1CCOCC1.CCOc1cc2nc(-c3[nH]ncc3NC(=O)c3c(F)cccc3F)[nH]c2cc1C(=O)O.O=C(Nc1cn[nH]c1-c1nc2c(CO)cc(Cl)cc2[nH]1)c1c(F)cccc1F.O=C(Nc1cn[nH]c1-c1nc2ccc(OCCC3CCNCC3)cc2[nH]1)c1c(F)cccc1F.O=C(Nc1cn[nH]c1-c1nc2ncncc2[nH]1)c1c(F)cccc1F |
| InChI | InChI=1S/C29H32F2N6O4.C24H22F2N6O4.C24H24F2N6O2.C20H15F2N5O4.C18H12ClF2N5O2.C15H9F2N7O/c1-29(2,3)41-28(39)37-12-9-17(10-13-37)11-14-40-18-7-8-21-22(15-18)34-26(33-21)25-23(16-32-36-25)35-27(38)24-19(30)5-4-6-20(24)31;1-2-36-19-11-17-16(10-13(19)24(34)32-6-8-35-9-7-32)28-22(29-17)21-18(12-27-31-21)30-23(33)20-14(25)4-3-5-15(20)26;25-16-2-1-3-17(26)21(16)24(33)31-20-13-28-32-22(20)23-29-18-5-4-15(12-19(18)30-23)34-11-8-14-6-9-27-10-7-14;1-2-31-15-7-13-12(6-9(15)20(29)30)24-18(25-13)17-14(8-23-27-17)26-19(28)16-10(21)4-3-5-11(16)22;19-9-4-8(7-27)15-12(5-9)23-17(25-15)16-13(6-22-26-16)24-18(28)14-10(20)2-1-3-11(14)21;16-7-2-1-3-8(17)11(7)15(25)22-9-5-20-24-12(9)14-21-10-4-18-6-19-13(10)23-14/h4-8,15-17H,9-14H2,1-3H3,(H,32,36)(H,33,34)(H,35,38);3-5,10-12H,2,6-9H2,1H3,(H,27,31)(H,28,29)(H,30,33);1-5,12-14,27H,6-11H2,(H,28,32)(H,29,30)(H,31,33);3-8H,2H2,1H3,(H,23,27)(H,24,25)(H,26,28)(H,29,30);1-6,27H,7H2,(H,22,26)(H,23,25)(H,24,28);1-6H,(H,20,24)(H,22,25)(H,18,19,21,23) |
| InChIKey | BFYHLXIWLAEDGQ-UHFFFAOYSA-N |
| XLogP | 22.99 |
| TPSA | 710.10 Ų |
| H-Bond Donors | 21 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 195 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2702.00 |
| LogP ≤ 5 | 22.99 |
| H-Bond Donors ≤ 5 | 21 |
| H-Bond Acceptors ≤ 10 | 31 |